The preparation developed in Novosibirsk, will test for a brain cancer therapy

The preparation for therapy of a cancer of a mammary gland on the basis of the first in Russian Federation a gene-modified onkolitichesky virus ospovaktsiony, developed by Novosibirsk scientists, successfully passed preliminary researches and now is at the first stage of clinical trials. It was developed at IKHBFM HORTICULTURAL SOCIETY REGIONAL REAL ESTATE AGENCY together with FEDERAL STATE-FINANCED INSTITUTION OF SCIENCE STATE RESEARCH CENTER WB "VEKTOR" ROSPOTREBNADZOR and company "Onkostar" (the resident "Skolkovo"). — Our preparation — is a virus, a live genetically modified virus ospovaktsiny. We removed two from its genome vital for life of a virus of a gene, and instead of...